Moody Aldrich Partners LLC Novo Cure LTD Transaction History

Moody Aldrich Partners LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Jul 30, 2020	SELL	$57.2 - $74.41 $1.76 Million - $2.28 Million	-30,682 Closed	0 $0
Q1 2020 May 07, 2020	SELL	$57.05 - $95.75 $3,936 - $6,606	-69 Reduced 0.22%	30,682 $2.07 Million
Q4 2019 Feb 07, 2020	BUY	$68.3 - $93.8 $60,445 - $83,013	885 Added 2.96%	30,751 $2.59 Million
Q3 2019 Nov 12, 2019	BUY	$61.86 - $97.8 $1.85 Million - $2.92 Million	29,866 New	29,866 $2.23 Million

290

75.1M

1.77M

538K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $1.86B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Moody Aldrich Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Moody Aldrich Partners LLC with notifications on news.